Purchases are not available yet. You can browse the site and sign in.
What Niacin Does in a Microdosing Stack and Its Risks · Microdosing College
Substances
What Niacin Does in a Microdosing Stack (and Its Real Risks)
By Microdosing College Editorial·Last updated July 20, 2026·8 min read
Niacin in a microdosing stack is more than just a vitamin add-on — it is the ingredient that generates the most questions and the most caution among educators and clinicians. If you have been reading about the Stamets stack, you have already encountered the three-part combination: psilocybin (from legal Dutch truffles), Lion's Mane mushroom, and niacin (vitamin B3). This article focuses on the niacin component specifically — what the proposed rationale is, what the flush feels like, and where the genuine safety concerns lie.
Nothing in this article is a recommendation to use niacin or any stack. We describe what is proposed, what is known from existing pharmacological and clinical literature, and what questions you must answer before making any decision — ideally with a clinician and after completing our .
The inclusion of niacin in Paul Stamets' proposed protocol rests on a theory, not a proven mechanism. Stamets has described niacin as a "driver" that may help psilocybin and Lion's Mane compounds reach peripheral and central nervous system tissue more effectively. The proposed pathway relates to niacin's well-established vasodilatory effect: at doses above roughly 50 mg, immediate-release niacin triggers a prostaglandin-mediated flush that causes capillary dilation and skin reddening. The reasoning, as Stamets has articulated publicly, is that this vasodilation could push lipid-soluble compounds deeper into tissue — including across the blood-brain barrier.
This hypothesis is biologically plausible in outline. Niacin's flush mechanism is well-documented: it activates GPR109A (the niacin receptor on immune and fat cells), stimulating prostaglandin D2 and E2 release, which dilates cutaneous blood vessels (Benyo et al., 2005, Journal of Clinical Investigation). Whether this meaningfully alters the CNS delivery of psilocin — the active metabolite of psilocybin — or Lion's Mane compounds such as hericenones is unproven. No peer-reviewed human study has tested the three-ingredient combination as a stack, and no controlled trial has verified enhanced CNS penetration from this pairing. The rationale remains theoretical.
Mori et al. (2010), writing in Mycology, identified hericenones and erinacines as the key NGF-stimulating compounds in Lion's Mane (Hericium erinaceus) — a finding that underpins the mushroom's inclusion in the stack, but that paper says nothing about niacin's role in transporting those compounds (Mori et al., 2010, Tandfonline). A 2025 systematic review in Frontiers in Nutrition found the overall human clinical evidence for Lion's Mane remains limited and mixed (Frontiers in Nutrition, 2025), which is the honest context for any claim about the stack as a whole.
The niacin flush: what it is and what it feels like
The flush is the most immediately noticeable effect of immediate-release niacin at stack-typical doses (usually cited as 100–200 mg in Stamets-protocol discussions). It is not an allergic reaction and not a sign of harm — but it is uncomfortable for many people and alarming if unexpected.
Typically, the flush begins within 20–30 minutes of taking immediate-release niacin on an empty or semi-empty stomach. You may notice:
A warm, prickling or tingling sensation starting in the face, ears, and neck
Visible skin reddening, sometimes extending to the chest and arms
A feeling of heat under the skin that can last 30–60 minutes
Occasional itching or mild headache
The flush is attenuated — but not eliminated — by taking niacin with food, by taking a low-dose aspirin (325 mg) 30 minutes before (this blunts prostaglandin release), or by using gradual-release formulations. However, gradual-release ("no-flush") niacin does not produce the flush because it is absorbed more slowly and produces less peak prostaglandin release — not because it is pharmacologically equivalent. This distinction matters for the stack's stated rationale, since if the flush is the proposed mechanism, no-flush niacin may simply not do what the theory proposes.
For most healthy adults, the flush at doses of 100–200 mg is an inconvenience, not a danger. However, this changes meaningfully at higher doses and in people with certain health conditions.
Real risks: when niacin at higher doses becomes a concern
Niacin is a vitamin — but "vitamin" does not mean harmless at any dose. The risks that matter clinically include:
Liver toxicity. Sustained-release niacin formulations carry a documented risk of hepatotoxicity at therapeutic doses (1,000–3,000 mg/day), which is the range used in lipid management. Case reports and clinical trials in cholesterol management have documented elevated liver enzymes and, in rare cases, fulminant liver failure at these doses. Immediate-release niacin is less hepatotoxic than sustained-release at equivalent doses, but both require liver monitoring when used over months at gram-level doses. Even at lower doses, people with pre-existing liver disease should avoid supplemental niacin entirely unless specifically directed by a physician. The U.S. National Institutes of Health Office of Dietary Supplements notes that the tolerable upper intake level (UL) for niacin in adults is set at 35 mg/day from supplements to avoid flushing — well below stack-typical doses.
Drug interactions. Niacin interacts with several medications that are common in microdosing-age adults:
Statins (cholesterol medications): combining niacin with statins raises the risk of myopathy and rhabdomyolysis (muscle breakdown); this combination is now generally discouraged in clinical lipid guidelines.
Anticoagulants (warfarin, some newer anticoagulants): niacin can potentiate bleeding risk.
Diabetes medications: niacin raises blood glucose and can antagonise insulin or oral hypoglycaemics.
Antihypertensives: the vasodilatory flush can potentiate blood-pressure-lowering medications, causing dizziness or drops in blood pressure, particularly when standing.
Gout. Niacin elevates uric acid by competing with urate for renal excretion; it is typically avoided in people with a history of gout.
Pregnancy. High-dose niacin supplements have not been proven safe in pregnancy; standard dietary sources are considered adequate and supplemental megadoses should be avoided.
If any of the above apply to you, the niacin component of the Stamets stack may be contraindicated regardless of how you feel about psilocybin or Lion's Mane. This is a specific, concrete clinical question — not a general wellness consideration — and it requires a genuine conversation with a prescribing clinician who knows your medications and history. Our health screener will flag these categories and help you structure that conversation.
How to approach the stack honestly
If you have read the Stamets stack explainer and are considering adding niacin, the clearest honest framework is:
Understand that the three-way stack is unproven. The rationale is theoretically grounded but has not been tested in a controlled human study. You are not replicating a clinical protocol — you are experimenting based on a hypothesis.
Start low and expect the flush. If you decide to try niacin after appropriate medical clearance, begin at the lowest meaningful dose (some sources suggest starting around 50 mg immediate-release) to test your personal flush response before moving higher. The flush varies enormously between individuals.
Use immediate-release niacin if you are following the theoretical rationale. No-flush (inositol hexanicotinate) and extended-release forms behave differently pharmacologically; they are not equivalent substitutes for the flush-based hypothesis.
Get your liver enzymes checked if you plan to use niacin for more than a few weeks at doses above 100 mg/day. This is standard clinical practice in niacin-based lipid therapy and sensible for extended supplementation.
Do not combine with statins or anticoagulants without explicit guidance from your prescribing doctor. These combinations carry documented harm risk.
For a broader look at which conditions and medications warrant extra caution with microdosing in general, see microdosing contraindications.
Who should skip niacin entirely
To be direct: the niacin component of the stack is the part most likely to create a real medical problem for people with common health conditions. You should not add supplemental niacin to any routine — including a microdosing stack — if you have liver disease (including fatty liver), active peptic ulcer disease, a personal history of gout, are taking statins or anticoagulants, or are pregnant or breastfeeding.
The psilocybin and Lion's Mane portions of the Stamets stack carry their own separate considerations (covered in our contraindications guide). But niacin is the one ingredient with the clearest, most mainstream clinical literature around hepatotoxicity and drug interactions — because it has been used at therapeutic doses for decades in cardiovascular medicine, generating a substantial safety record.
If you are unsure whether niacin is appropriate for you, that uncertainty is itself a signal: use the screener, speak to a clinician, and do not assume that "it's just a vitamin" resolves the question.
Why is niacin included in the Stamets microdosing stack?+
Paul Stamets proposed that niacin's vasodilatory flush helps deliver psilocybin and Lion's Mane compounds more effectively to neural tissue. The mechanism is biologically plausible but has not been confirmed in a controlled human trial — it remains a hypothesis.
What does the niacin flush feel like and is it dangerous?+
The flush is a warm, tingling redness of the skin — usually face, neck, and chest — lasting 30–60 minutes after taking immediate-release niacin above roughly 50 mg. For healthy adults at stack-typical doses (100–200 mg) it is uncomfortable but not medically dangerous. It can be alarming if unexpected.
Can I use no-flush niacin to avoid the side effect?+
No-flush (inositol hexanicotinate) and extended-release niacin reduce flushing by slowing absorption. Because the flush is the proposed delivery mechanism in the Stamets rationale, these forms may not serve the same theoretical purpose — and extended-release niacin carries a higher risk of liver toxicity at equivalent doses.
Is niacin safe to add to a microdosing routine?+
No supplement is simply 'safe' for everyone. Niacin at doses used in stacks carries real risks for people with liver disease, gout, or who take statins or anticoagulants. Check our screener and speak with a clinician before adding it to any routine.
Does niacin interact with any common medications?+
Yes. Niacin interacts with statins (risk of muscle damage), anticoagulants like warfarin (increased bleeding risk), diabetes medications (raises blood glucose), and antihypertensives (enhanced blood pressure drop). These are not minor interactions — discuss with your prescribing clinician before combining.
This guide is general educational information about microdosing, not medical advice and not a recommendation to use any substance. It can't account for your personal health. If you take medication or live with a mental-health condition, speak with a qualified professional before making any decision.
